Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
09/08/2025
The Nikkei 225 index regained lost ground in the morning session, rising 0.6% to 41,057.10 points.
Latest
1 m ago
Ningde Times Ginxiangwo mining end confirmed to stop production! Relevant sources: no short-term plans for resumption.
2 m ago
China Earthquake Networks Center automatically determined: A magnitude 6.2 earthquake occurred near the east of the Thousand Islands on August 9th at 22:04. Please refer to the official bulletin for the final result.
8 m ago
German Research Centre for Geosciences: 6.14 magnitude earthquake occurred east of the Thousand Islands Islands.
22 m ago
Wuhan sees a resurgence of "sunshine plate" with comprehensive measures to help the real estate market stabilize and accelerate.
22 m ago
Boran Biotechnology Port Stock Exchange announcement: The self-developed Bovolu injection (dulaglutide injection) has obtained market approval from the National Medical Products Administration for blood sugar control in adult type 2 diabetes patients. Bovolu is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist, and its commercialization in mainland China is carried out in cooperation with Shang Yao Holdings by the company.
See all latest